Nurse Practitioner, Family · Elk City, OK
NPI
1780281568
Since 2020
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2406 Bell Ave
Elk City, OK, 73644
Phone (580) 303-7944
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
97,206 services
Medicare patients, 2024
416
Average age 72
Drug cost, 2024
$3.0M
3,681 prescriptions
Company payments, 2025
$288
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Latosha L Redd was code J1602 (injection, golimumab, 1 mg, for intravenous use), 27,999 times for 58 patients. In total Latosha L Redd billed 97,206 services in 80 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 27,999 | 58 | $8.58 | $240K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 15,000 | 12 | $0.88 | $13K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 9,030 | 14 | $8.06 | $73K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 4,890 | 30 | $24.82 | $121K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,964 | 142 | $0.71 | $1,386 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 820 | 76 | $0.23 | $187 |
| 85025 Blood Count | Office | 784 | 348 | $7.50 | $5,877 |
| 85652 Clinical Chemistry | Office | 770 | 345 | $2.63 | $2,024 |
| 86140 Clinical Chemistry | Office | 769 | 343 | $5.01 | $3,853 |
| 99214 Office E&M - Established | Office | 728 | 325 | $69.22 | $50K |
| 80053 Clinical Chemistry | Office | 652 | 325 | $10.25 | $6,684 |
| 36415 Venipuncture Blood Collection | Office | 590 | 284 | $7.35 | $4,337 |
| 96372 Injection Administration | Office | 355 | 166 | $7.99 | $2,835 |
| 96375 Injection Administration | Office | 324 | 92 | $9.12 | $2,956 |
| 86235 Immunoassay | Office | 321 | 33 | $17.57 | $5,640 |
By year: 2022 $121K for 8,162 services; 2023 $106K for 7,881 services; 2024 $1.3M for 97,206 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 784 | 348 | $7.50 | $5,877 |
| 85652 Clinical Chemistry | 770 | 345 | $2.63 | $2,024 |
| 86140 Clinical Chemistry | 769 | 343 | $5.01 | $3,853 |
| 80053 Clinical Chemistry | 652 | 325 | $10.25 | $6,684 |
| 36415 Venipuncture Blood Collection | 590 | 284 | $7.35 | $4,337 |
| 86235 Immunoassay | 321 | 33 | $17.57 | $5,640 |
| 86480 Immunoassay | 148 | 144 | $60.33 | $8,929 |
| 82306 Clinical Chemistry | 121 | 83 | $28.82 | $3,487 |
| 82607 Clinical Chemistry | 115 | 80 | $14.78 | $1,700 |
| 82746 Clinical Chemistry | 115 | 80 | $14.41 | $1,657 |
Medicare prescription drug claims, 2024
In 2024, the drug Latosha L Redd prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 782 prescriptions and refills. In total Latosha L Redd wrote 3,681 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 782 | 1,216 | 158 | $29K |
| Methotrexate Methotrexate Sodium | 394 | 608 | 90 | $6,165 |
| Sulfasalazine Dr Sulfasalazine | 323 | 443 | 78 | $7,400 |
| Prednisone Generic | 279 | 339 | 99 | $1,527 |
| Leflunomide Generic | 189 | 260 | 49 | $7,703 |
| Celecoxib Generic | 179 | 233 | 42 | $3,283 |
| Gabapentin Generic | 138 | 178 | 24 | $1,038 |
| Meloxicam Generic | 109 | 154 | 31 | $676 |
| Sulfasalazine Generic | 102 | 159 | 24 | $2,341 |
| Enbrel Sureclick Etanercept | 98 | 98 | 14 | $740K |
| Humira(Cf) Pen Adalimumab | 97 | 99 | 18 | $959K |
| Allopurinol Generic | 95 | 138 | 22 | $479 |
| Folic Acid Generic | 55 | 122 | 18 | $398 |
| Pilocarpine Hcl Generic | 49 | 62 | 12 | $2,920 |
| Simponi Aria Golimumab | 48 | 58 | 13 | $384K |
Brand drugs: - claims; generic drugs: 2,825 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Latosha L Redd $288 ($288 in general payments such as food, travel and fees) from 5 companies. The largest payer was GlaxoSmithKline, LLC. with $132.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.